Blockchain Registration Transaction Record

BioMed X Launches Women's Health R&D Accelerator with Gates Foundation

BioMed X launches XFem Labs women's health accelerator with Gates Foundation support, focusing on non-hormonal contraception research to address global healthcare gaps affecting millions.

This initiative addresses a critical gap in women's healthcare by focusing on non-hormonal contraceptive options, which could benefit the 257 million women worldwide who currently face barriers to adequate family planning. The development of safer, more accessible contraceptive methods has far-reaching implications for women's autonomy, health outcomes, and economic opportunities, particularly in low-income regions where current options are limited. By bridging academic research with practical applications, this accelerator could accelerate the delivery of innovative solutions that improve reproductive health globally, reducing unintended pregnancies and empowering women to make informed choices about their bodies and futures.